Guardant Health, INC Form 4 insider transactions

Craig Eagle, Chief Medical Officer of Guardant Health, reports the vesting of restricted stock units and subsequent tax withholding.

Darya Chudova, Chief Technology Officer of Guardant Health, reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.

Director Meghan V. Joyce reported the vesting of restricted stock units into 66 shares of Guardant Health, Inc. common stock on May 4, 2025.

AmirAli Talasaz, Co-CEO of Guardant Health, sold shares of the company's common stock on May 1st and 2nd, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Director Steve Krognes reported the vesting of restricted stock units and subsequent acquisition of common stock in Guardant Health, Inc.

Director Tariq Musa sold 116 shares of Guardant Health, Inc. on April 17, 2025, at a price of $44.79 per share.

Director Tariq Musa reports the acquisition and disposal of Guardant Health, Inc. common stock and restricted stock units.

Chief Legal Officer John G. Saia of Guardant Health, Inc. reports the vesting of restricted stock units and subsequent stock sales to cover tax obligations.

Director Myrtle S. Potter reports a transaction involving Guardant Health, Inc. common stock and restricted stock units.

Director Meghan V. Joyce reports the vesting and acquisition of common stock through restricted stock units.

John G. Saia, Chief Legal Officer of Guardant Health, reports transactions involving restricted stock units and common stock.

Kumud Kalia, Chief Information Officer of Guardant Health, reports the vesting and subsequent tax withholding of restricted stock units.

Chris Freeman, Chief Commercial Officer of Guardant Health, reports the vesting and disposal of restricted stock units to cover tax obligations.

Craig Eagle, Chief Medical Officer of Guardant Health, Inc., reports the vesting and tax withholding of restricted stock units.

Darya Chudova, Chief Technology Officer of Guardant Health, reports the vesting and tax withholding of restricted stock units.

Chief Financial Officer of Guardant Health, Michael Bell, reports the vesting of restricted stock units and subsequent stock transactions to cover tax obligations.

Director Steve Krognes reported the vesting and conversion of restricted stock units into common stock of Guardant Health, Inc.

AmirAli Talasaz, Co-Chief Executive Officer of Guardant Health, Inc., reports the vesting and subsequent tax withholding of restricted stock units.

Helmy Eltoukhy, Co-CEO of Guardant Health, reports the vesting and subsequent tax withholding of restricted stock units, resulting in adjustments to his beneficial ownership.

Director Tariq Musa reported selling 116 shares of Guardant Health, Inc. common stock on March 19, 2025, at a price of $43.7 per share.

Director Tariq Musa reported the disposition of 249 shares of Common Stock and 249 Restricted Stock Units of Guardant Health, Inc. on March 15, 2025.

Chief Legal Officer John G. Saia of Guardant Health, Inc. reports the vesting of restricted stock units and subsequent tax withholding.

Director Myrtle S. Potter reports a transaction involving Guardant Health, Inc. common stock on March 15, 2025.

Kumud Kalia, Chief Information Officer of Guardant Health, reports the vesting of restricted stock units, a tax withholding, and a sale of shares.

Chris Freeman, Chief Commercial Officer of Guardant Health, reports the vesting and subsequent tax withholding related to restricted stock units.

Craig Eagle, Chief Medical Officer of Guardant Health, reports the vesting and subsequent tax withholding related to restricted stock units.

Michael Brian Bell, CFO of Guardant Health, Inc., reports the vesting and subsequent tax withholding of restricted stock units.

Co-Chief Executive Officer AmirAli Talasaz reports the disposition and acquisition of Guardant Health, Inc. stock related to the vesting of restricted stock units.

Helmy Eltoukhy, Co-Chief Executive Officer of Guardant Health, reports the vesting of restricted stock units and subsequent tax withholding.

Co-Chief Executive Officer AmirAli Talasaz reports the acquisition of restricted stock units in Guardant Health, Inc.